July 27 (Reuters) – Boston Scientific's board has approved a new company-wide restructuring plan aimed at cutting costs and to better position the company for future growth, the medical device maker
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Trump Media's revenue more than triples in third quarter
Nov 9 (Reuters) - Trump Media & Technology Group on Monday reported third-quarter revenue that…
BRIEF-Direcional Q3 net profit 201 million reais vs IBES estimate 221 million reais
Nov 9 (Reuters) - Direcional Engenharia S.A.: * Q3 NET PROFIT 200.7 MILLION REAIS VERSUS…
Skydance details cost cuts, sets streaming bundle for early next year
By Lisa Richwine and Harshita Mary Varghese LOS ANGELES, Nov 9 (Reuters) - Skydance on…
